SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-21-006286
Filing Date
2021-05-26
Accepted
2021-05-26 08:37:10
Documents
12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT azrxs3_may202021.htm S-3 738758
2 AT THE MARKET OFFERING AGREEMENT, DATED MAY 20, 2021 ex_12.htm EX-1.2 249711
3 OPINION OF LOWENSTEIN SANDLER LLP ex_51.htm EX-5.1 30414
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - MAZARS USA LLP ex_231.htm EX-23.1 3888
5 IMAGE azurrx_logo000.jpg GRAPHIC 5202
6 IMAGE azurrx_logo001.jpg GRAPHIC 5184
7 IMAGE azurrx_logo002.jpg GRAPHIC 5184
8 IMAGE footer.jpg GRAPHIC 9260
9 IMAGE logo1.jpg GRAPHIC 7171
10 IMAGE logo2.jpg GRAPHIC 5891
11 IMAGE logo3.jpg GRAPHIC 5891
12 IMAGE logo4.jpg GRAPHIC 5891
  Complete submission text file 0001654954-21-006286.txt   1093355
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256476 | Film No.: 21962814
SIC: 2834 Pharmaceutical Preparations